By James Edwards The Trump administration’s drug importation rule takes another step in seeking the holy grail of lower drug costs. It’s a noble quest destined for failure. Like the recent order pegging Medicare pharmaceutical payments to those of foreign government-run health systems, drug importation too will backfire. All Americans want foreign […]